X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (98479) 98479
Book Review (11538) 11538
Publication (3439) 3439
Newsletter (2806) 2806
Book Chapter (637) 637
Conference Proceeding (483) 483
Magazine Article (341) 341
Newspaper Article (306) 306
Dissertation (285) 285
Trade Publication Article (67) 67
Book / eBook (60) 60
Government Document (38) 38
Web Resource (32) 32
Reference (25) 25
Paper (12) 12
Data Set (6) 6
Journal / eJournal (4) 4
Report (4) 4
Transcript (2) 2
Archival Material (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (73480) 73480
humans (60790) 60790
heparin (38322) 38322
male (25551) 25551
female (25409) 25409
animals (22726) 22726
heparin - therapeutic use (16392) 16392
middle aged (15504) 15504
heparin - pharmacology (13723) 13723
adult (13493) 13493
aged (12289) 12289
abridged index medicus (11105) 11105
anticoagulants - therapeutic use (10819) 10819
heparin - administration & dosage (9447) 9447
hematology (9198) 9198
anticoagulants (8743) 8743
molecular-weight heparin (7951) 7951
peripheral vascular disease (7852) 7852
biochemistry & molecular biology (7086) 7086
heparin - adverse effects (6768) 6768
thrombosis (6667) 6667
surgery (6397) 6397
rats (6303) 6303
risk factors (5799) 5799
time factors (5738) 5738
cardiac & cardiovascular systems (5591) 5591
anticoagulants - administration & dosage (5574) 5574
treatment outcome (5322) 5322
anticoagulants - adverse effects (5188) 5188
heparin - metabolism (5120) 5120
mice (5046) 5046
heparin, low-molecular-weight - therapeutic use (4876) 4876
research (4700) 4700
pregnancy (4427) 4427
medicine, general & internal (4356) 4356
glycosaminoglycans (4316) 4316
prevention (4185) 4185
unfractionated heparin (4157) 4157
venous thromboembolism (4139) 4139
thromboembolism (4011) 4011
pharmacology & pharmacy (3821) 3821
old medline (3707) 3707
fibrinolytic agents - therapeutic use (3685) 3685
deep-vein thrombosis (3582) 3582
analysis (3567) 3567
aged, 80 and over (3415) 3415
dose-response relationship, drug (3357) 3357
kinetics (3294) 3294
adolescent (3288) 3288
prospective studies (3270) 3270
heparin - chemistry (3265) 3265
cells, cultured (3229) 3229
thrombocytopenia - chemically induced (3224) 3224
binding (3185) 3185
protein binding (3127) 3127
therapy (3117) 3117
anticoagulation (3105) 3105
blood coagulation - drug effects (3092) 3092
anticoagulants - pharmacology (3066) 3066
molecular sequence data (3013) 3013
retrospective studies (2991) 2991
proteins (2859) 2859
thrombin (2764) 2764
cell biology (2719) 2719
molecular weight (2645) 2645
heparin-induced thrombocytopenia (2638) 2638
postoperative complications - prevention & control (2631) 2631
venous thrombosis (2627) 2627
rabbits (2625) 2625
thromboembolism - prevention & control (2582) 2582
care and treatment (2564) 2564
thrombosis - prevention & control (2539) 2539
blood (2524) 2524
enoxaparin (2496) 2496
amino acid sequence (2477) 2477
cattle (2455) 2455
risk (2453) 2453
blood coagulation tests (2446) 2446
binding sites (2426) 2426
health aspects (2424) 2424
expression (2420) 2420
drug therapy (2411) 2411
in vitro techniques (2391) 2391
cardiopulmonary bypass (2340) 2340
partial thromboplastin time (2285) 2285
heparin, low-molecular-weight - administration & dosage (2246) 2246
cancer (2239) 2239
hemorrhage - chemically induced (2234) 2234
pulmonary embolism (2231) 2231
activation (2208) 2208
child (2193) 2193
drug therapy, combination (2192) 2192
management (2173) 2173
warfarin (2161) 2161
coagulation (2132) 2132
diagnosis (2106) 2106
thrombolytic therapy (2082) 2082
prophylaxis (2069) 2069
blood coagulation (2043) 2043
dogs (2040) 2040
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (42) 42
Online Resources - Online (23) 23
Gerstein Science - Theses (4) 4
University Archives - Archives (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Stacks (2) 2
Thomas Fisher Rare Book - Rare Book (2) 2
Collection Dvlpm't (Acquisitions) - Pharmacy (1) 1
Credit Valley Hospital - Closed Orders (1) 1
Gerstein Science - Pharmacy (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Online (1) 1
Toronto East General Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (87379) 87379
German (4288) 4288
French (3150) 3150
Russian (2172) 2172
Japanese (1106) 1106
Spanish (1099) 1099
Italian (1012) 1012
Chinese (546) 546
Polish (535) 535
Czech (256) 256
Portuguese (218) 218
Hungarian (163) 163
Korean (132) 132
Dutch (123) 123
Swedish (123) 123
Turkish (106) 106
Danish (97) 97
Romanian (87) 87
Bulgarian (66) 66
Norwegian (62) 62
Slovak (53) 53
Ukrainian (50) 50
Croatian (37) 37
Finnish (34) 34
Serbian (28) 28
Hebrew (23) 23
Slovenian (9) 9
Lithuanian (8) 8
Afrikaans (6) 6
Persian (6) 6
Bosnian (2) 2
Icelandic (2) 2
Arabic (1) 1
Estonian (1) 1
Greek (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Colloids and Surfaces B: Biointerfaces, ISSN 0927-7765, 10/2015, Volume 134, p. 413
Sketchmap of the preparation of positive and negative charge modified chitosan scaffolds by APTE and Heparin, respectively. 
Heparin
Journal Article
Journal Article
Carbohydrate Research, ISSN 0008-6215, 03/2015, Volume 405, p. 110
Journal Article
by Schulman, Sam and Kakkar, Ajay K and Goldhaber, Samuel Z and Schellong, Sebastian and Eriksson, Henry and Mismetti, Patrick and Christiansen, Anita Vedel and Friedman, Jeffrey and Le Maulf, Florence and Peter, Nuala and Kearon, Clive and Schulman, S and Eriksson, H and Goldhaber, S and Kakkar, A and Kearon, C and Mismetti, P and Schellong, S and Bergqvist, D and Tijssen, J and Prins, M. [=Martin H.] and Robben, S and Büller, H and Otten, H. M and Brandjes, D and Peters, R and Mac Gillavry, M. R and Gan, E and Salem, H and Baker, R and Blomberry, P and Curnow, J and Annichino-Bizzacch, J. M and Brandao Panico, M. D and Timi Ribas, J. R and Fernandes Manenti, E. R and Miranda, F and Moraes, J and Raev, D and Mollov, M and Peneva, M and Milanov, S and Anderson, D and Crowther, M and Dolan, S and Eikelboom, J and Game, M and Kahn, S and Kassis, J and Ritchie, B and Solymoss, S and Rodger, M and Yeo, E and Milot, A and Klinke, P and Chen, W and Zhihong, L and Chunxue, B and Jinming, L and Jiwei, Z and Jie, C and Jina, K and Yuqi, W and Zhongqi, Y and Hua, W and Kejing, Y and Bonan, L and Yadong, Y and Changwei, L and Jin, Z and Yongcheng, D and Spinar, J and Maly, R and Cizek, V and Bercikova, J and Cervinka, P and Lang, P and Jirka, V and Oral, I and Reichert, P and Kotik, L and Pojsl, S and Klimovic, T and Husted, S and Nielsen, H and Friis, E and Skødebjerg Kristensen, K and Mottier, D and El Kouri, D and Bleher, Y and Leroux, L and Boda, Z and Sereg, M and Riba, M and Hiremath, J. S and Kareem, S and Banker, D. N and Gadkari, M and Parakh, R and Suresh, K. R and ... and RE-COVER II Trial Investigators
Circulation, ISSN 0009-7322, 2014, Volume 129, Issue 7, pp. 764 - 772
Dabigatran and warfarin have been compared for the treatment of acute venous thromboembolism (VTE) in a previous trial. We undertook this study to extend those... 
Antagonists & inhibitors | Recurrence | Thrombin | Warfarin | Hemorrhage | Venous thromboembolism | CARDIAC & CARDIOVASCULAR SYSTEMS | FONDAPARINUX | THROMBOSIS | MOLECULAR-WEIGHT HEPARIN | RIVAROXABAN | INITIAL TREATMENT | PERIPHERAL VASCULAR DISEASE | ORAL ANTICOAGULANT-THERAPY | APIXABAN | UNFRACTIONATED HEPARIN | Anticoagulants - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Heparin - administration & dosage | Heparin, Low-Molecular-Weight - adverse effects | Warfarin - adverse effects | Male | Antithrombins - administration & dosage | Dabigatran | Heparin - adverse effects | Warfarin - administration & dosage | Venous Thromboembolism - drug therapy | Young Adult | Benzimidazoles - administration & dosage | Adult | Female | Benzimidazoles - adverse effects | Venous Thromboembolism - epidemiology | beta-Alanine - analogs & derivatives | Acute Disease | beta-Alanine - adverse effects | Double-Blind Method | Hemorrhage - epidemiology | Risk Factors | beta-Alanine - administration & dosage | Anticoagulants - adverse effects | Antithrombins - adverse effects | Adolescent | Aged | Hemorrhage - chemically induced | Heparin, Low-Molecular-Weight - administration & dosage | Usage | Care and treatment | Dabigatran etexilate | Thromboembolism | Index Medicus | Abridged Index Medicus | Anticoagulants | Benzimidazoles | Heparin, Low-Molecular-Weight | Life Sciences | Venous Thromboembolism | Antithrombins | Heparin | beta-Alanine
Journal Article
Ethik in der Medizin, ISSN 0935-7335, 03/2019, Volume 31, Issue 1, p. 83
Journal Article
Ethik in der Medizin, ISSN 0935-7335, 03/2019, Volume 31, Issue 1, p. 87
Journal Article
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e195S - e226S
Background: This guideline addressed VTE prevention in hospitalized medical patients, outpatients with cancer, the chronically immobilized, long-distance... 
CATHETER-RELATED THROMBOSIS | GRADUATED COMPRESSION STOCKINGS | SURGICAL ADJUVANT BREAST | COA REDUCTASE INHIBITORS | VENOUS THROMBOEMBOLIC DISEASE | RESPIRATORY SYSTEM | LONG-HAUL FLIGHTS | MOLECULAR-WEIGHT HEPARIN | DEEP-VEIN THROMBOSIS | HOSPITALIZED MEDICAL PATIENTS | CRITICALLY-ILL PATIENTS | CRITICAL CARE MEDICINE | Humans | Heparin, Low-Molecular-Weight - adverse effects | Immobilization | Heparin - therapeutic use | Hemorrhage - prevention & control | Heparin - adverse effects | Heparin, Low-Molecular-Weight - therapeutic use | Heparin - pharmacokinetics | Venous Thromboembolism - drug therapy | Venous Thromboembolism - blood | Fibrinolytic Agents - adverse effects | Neoplasms - complications | Venous Thromboembolism - prevention & control | Neoplasms - blood | Societies, Medical | Fibrinolytic Agents - pharmacokinetics | Fibrinolytic Agents - therapeutic use | Fondaparinux | Stockings, Compression | Polysaccharides - therapeutic use | Intermittent Pneumatic Compression Devices | Risk Factors | Polysaccharides - adverse effects | Combined Modality Therapy | Hemorrhage - blood | Hospitalization | Evidence-Based Medicine | Ambulatory Care | Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Venous Thromboembolism - etiology | Travel | Heparin, Low-Molecular-Weight - pharmacokinetics | Critical Care | Hemorrhage - chemically induced | Polysaccharides - pharmacokinetics | Index Medicus | Abridged Index Medicus | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Ethik in der Medizin, ISSN 0935-7335, 03/2019, Volume 31, Issue 1, p. 81
Article History: 
Heparin
Journal Article
Shui Chan xue bao, ISSN 1000-0615, 01/2017, Volume 41, Issue 11, pp. 1779 - 1787
Adhesins are critical to the infectious pathogens, thus identification of novel adhesins is very crucial to understanding the pathogen’s infection mechanism.... 
Heparin
Journal Article
Strahlentherapie und Onkologie, ISSN 0179-7158, 06/2013, Volume 189, Issue 6, p. 514
Journal Article
Chest, ISSN 0012-3692, 2007, Volume 132, Issue 4, pp. 1131 - 1139
Journal Article
La Revue de medecine interne, ISSN 0248-8663, 03/2014, Volume 35, Issue 3, p. 174
Bien que plus rares aujourd'hui, les thrombopenies induites par l'heparine (TIH) demeurent une complication iatrogene grave qu'il faut savoir reconnaitre. Une... 
Heparin
Journal Article
Journal Article
2000, Fundamental and clinical cardiology, ISBN 9780824702717, Volume 39, xix, 400
Book
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.